Edwards Lifesciences (EW) Tops Q4 EPS by 3c
Tweet
Share
E-mail
Get Alerts EW Hot Sheet
Price: $88.26 +0.01%
EPS Growth %: +10.4%
Financial Fact:
Diluted (in dollars per share): 0.65
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: +10.4%
Financial Fact:
Diluted (in dollars per share): 0.65
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Edwards Lifesciences (NYSE: EW) reported Q4 EPS of $0.64, $0.03 better than the analyst estimate of $0.61. Revenue for the quarter came in at $1.35 billion versus the consensus estimate of $1.33 billion.
For earnings history and earnings-related data on Edwards Lifesciences (EW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- B.Riley Assumes Anika Therapeutics (ANIK) at Buy
- Circle Internet stock climbs on TD Cowen upgrade, Fed rate hike
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
